论文部分内容阅读
作者采用氚标记胸腺嘧啶核苷掺入正常人T 淋巴细胞转化抑制试验检测直肠癌患者血清中免疫抑制因子,结果提示抑制因子检测可望作为直肠癌等肿瘤治疗的免疫指标。
The authors used technetium-labeled thymidine incorporation in normal human T-lymphocyte transformation inhibition assays to detect immunosuppressive factors in patients with rectal cancer. The results suggest that inhibitory factor detection is expected to be an immune indicator for cancer treatment such as rectal cancer.